A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)

W. M. Carroll, T. Saida, H. J. Kim, Jun-Ichi Kira, A. G. Kermode, C. P. Tsai, K. Fujihara, S. Kusunoki, M. Tanaka, K. K. Kim, D. Bates

研究成果: ジャーナルへの寄稿評論記事

7 引用 (Scopus)

抄録

Definite diagnosis of inflammatory demyelinating disease (multiple sclerosis (MS) and neuromyelitis optica (NMO)) may require time, but early treatment offers the opportunity to maximize patient outcomes. The purpose of this report is to provide guidance to facilitate early treatment decisions for patients with inflammatory demyelinating disease, before definitive diagnosis. Neurology experts reviewed the existing literature and clinical evidence. A treatment decision pathway was developed, defining patients for whom first-line MS disease-modifying therapies (a) are unlikely to be effective, (b) may be effective but require careful monitoring and (c) are likely to provide benefit. This algorithm seeks to ensure that patients, particularly those in Asia, receive appropriate treatment early in inflammatory demyelinating disease.

元の言語英語
ページ(範囲)1371-1380
ページ数10
ジャーナルMultiple Sclerosis Journal
19
発行部数10
DOI
出版物ステータス出版済み - 1 1 2013

Fingerprint

Neuromyelitis Optica
Demyelinating Diseases
Multiple Sclerosis
Therapeutics
Neurology

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

これを引用

A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica). / Carroll, W. M.; Saida, T.; Kim, H. J.; Kira, Jun-Ichi; Kermode, A. G.; Tsai, C. P.; Fujihara, K.; Kusunoki, S.; Tanaka, M.; Kim, K. K.; Bates, D.

:: Multiple Sclerosis Journal, 巻 19, 番号 10, 01.01.2013, p. 1371-1380.

研究成果: ジャーナルへの寄稿評論記事

Carroll, WM, Saida, T, Kim, HJ, Kira, J-I, Kermode, AG, Tsai, CP, Fujihara, K, Kusunoki, S, Tanaka, M, Kim, KK & Bates, D 2013, 'A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)', Multiple Sclerosis Journal, 巻. 19, 番号 10, pp. 1371-1380. https://doi.org/10.1177/1352458512471092
Carroll, W. M. ; Saida, T. ; Kim, H. J. ; Kira, Jun-Ichi ; Kermode, A. G. ; Tsai, C. P. ; Fujihara, K. ; Kusunoki, S. ; Tanaka, M. ; Kim, K. K. ; Bates, D. / A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica). :: Multiple Sclerosis Journal. 2013 ; 巻 19, 番号 10. pp. 1371-1380.
@article{56a152397c324fe68e2e0495a36ae124,
title = "A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)",
abstract = "Definite diagnosis of inflammatory demyelinating disease (multiple sclerosis (MS) and neuromyelitis optica (NMO)) may require time, but early treatment offers the opportunity to maximize patient outcomes. The purpose of this report is to provide guidance to facilitate early treatment decisions for patients with inflammatory demyelinating disease, before definitive diagnosis. Neurology experts reviewed the existing literature and clinical evidence. A treatment decision pathway was developed, defining patients for whom first-line MS disease-modifying therapies (a) are unlikely to be effective, (b) may be effective but require careful monitoring and (c) are likely to provide benefit. This algorithm seeks to ensure that patients, particularly those in Asia, receive appropriate treatment early in inflammatory demyelinating disease.",
author = "Carroll, {W. M.} and T. Saida and Kim, {H. J.} and Jun-Ichi Kira and Kermode, {A. G.} and Tsai, {C. P.} and K. Fujihara and S. Kusunoki and M. Tanaka and Kim, {K. K.} and D. Bates",
year = "2013",
month = "1",
day = "1",
doi = "10.1177/1352458512471092",
language = "English",
volume = "19",
pages = "1371--1380",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica)

AU - Carroll, W. M.

AU - Saida, T.

AU - Kim, H. J.

AU - Kira, Jun-Ichi

AU - Kermode, A. G.

AU - Tsai, C. P.

AU - Fujihara, K.

AU - Kusunoki, S.

AU - Tanaka, M.

AU - Kim, K. K.

AU - Bates, D.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Definite diagnosis of inflammatory demyelinating disease (multiple sclerosis (MS) and neuromyelitis optica (NMO)) may require time, but early treatment offers the opportunity to maximize patient outcomes. The purpose of this report is to provide guidance to facilitate early treatment decisions for patients with inflammatory demyelinating disease, before definitive diagnosis. Neurology experts reviewed the existing literature and clinical evidence. A treatment decision pathway was developed, defining patients for whom first-line MS disease-modifying therapies (a) are unlikely to be effective, (b) may be effective but require careful monitoring and (c) are likely to provide benefit. This algorithm seeks to ensure that patients, particularly those in Asia, receive appropriate treatment early in inflammatory demyelinating disease.

AB - Definite diagnosis of inflammatory demyelinating disease (multiple sclerosis (MS) and neuromyelitis optica (NMO)) may require time, but early treatment offers the opportunity to maximize patient outcomes. The purpose of this report is to provide guidance to facilitate early treatment decisions for patients with inflammatory demyelinating disease, before definitive diagnosis. Neurology experts reviewed the existing literature and clinical evidence. A treatment decision pathway was developed, defining patients for whom first-line MS disease-modifying therapies (a) are unlikely to be effective, (b) may be effective but require careful monitoring and (c) are likely to provide benefit. This algorithm seeks to ensure that patients, particularly those in Asia, receive appropriate treatment early in inflammatory demyelinating disease.

UR - http://www.scopus.com/inward/record.url?scp=84883164828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883164828&partnerID=8YFLogxK

U2 - 10.1177/1352458512471092

DO - 10.1177/1352458512471092

M3 - Review article

C2 - 23325588

AN - SCOPUS:84883164828

VL - 19

SP - 1371

EP - 1380

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 10

ER -